210 related articles for article (PubMed ID: 33205543)
1. Malignant transformation of oral submucous fibrosis: A systematic review and meta-analysis.
Kujan O; Mello FW; Warnakulasuriya S
Oral Dis; 2021 Nov; 27(8):1936-1946. PubMed ID: 33205543
[TBL] [Abstract][Full Text] [Related]
2. Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype.
Iocca O; Sollecito TP; Alawi F; Weinstein GS; Newman JG; De Virgilio A; Di Maio P; Spriano G; Pardiñas López S; Shanti RM
Head Neck; 2020 Mar; 42(3):539-555. PubMed ID: 31803979
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of betel quid chewing, tobacco use (in the form of cigarette smoking), and alcohol consumption on the risk of malignant transformation of oral submucous fibrosis (OSF): a case-control study in Hunan Province, China.
Liu B; Shen M; Xiong J; Yuan Y; Wu X; Gao X; Xu J; Guo F; Jian X
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Sep; 120(3):337-45. PubMed ID: 26130067
[TBL] [Abstract][Full Text] [Related]
4. Malignant transformation in oral submucous fibrosis: Tertiary level evidence: An umbrella review.
Gondivkar SM; Yuwanati M; Sarode SC; Gadbail AR; Gondivkar R; Mohsin SF; Gaikwad R
Oral Dis; 2024 May; 30(4):1818-1827. PubMed ID: 37650364
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological survey of oral submucous fibrosis in Xiangtan City, Hunan Province, China.
Tang JG; Jian XF; Gao ML; Ling TY; Zhang KH
Community Dent Oral Epidemiol; 1997 Apr; 25(2):177-80. PubMed ID: 9181294
[TBL] [Abstract][Full Text] [Related]
6. Malignant transformation of oral submucous fibrosis in Taiwan: A nationwide population-based retrospective cohort study.
Yang PY; Chen YT; Wang YH; Su NY; Yu HC; Chang YC
J Oral Pathol Med; 2017 Nov; 46(10):1040-1045. PubMed ID: 28295637
[TBL] [Abstract][Full Text] [Related]
7. Are There Betel Quid Mixtures Less Harmful than Others? A Scoping Review of the Association between Different Betel Quid Ingredients and the Risk of Oral Submucous Fibrosis.
Cirillo N; Duong PH; Er WT; Do CTN; De Silva MEH; Dong Y; Cheong SC; Sari EF; McCullough MJ; Zhang P; Prime SS
Biomolecules; 2022 May; 12(5):. PubMed ID: 35625592
[TBL] [Abstract][Full Text] [Related]
8. An enigmatic pathogenetic mechanism of hypoxia inducible factor - 1/2 alpha in the progression of fibrosis of oral submucous fibrosis and its malignant transformation: A systematic review and meta-analysis.
R K; Chandra A; Jain T; Singh N; Agrawal R
Arch Oral Biol; 2024 Jun; 162():105944. PubMed ID: 38492547
[TBL] [Abstract][Full Text] [Related]
9. Consumption of areca quid, cigarettes, and alcohol related to the comorbidity of oral submucous fibrosis and oral cancer.
Ho PS; Yang YH; Shieh TY; Huang IY; Chen YK; Lin KN; Chen CH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Nov; 104(5):647-52. PubMed ID: 17449298
[TBL] [Abstract][Full Text] [Related]
10. Malignant transformation of oral submucous fibrosis: overview of histopathological aspects.
Ray JG; Ranganathan K; Chattopadhyay A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):200-9. PubMed ID: 27422418
[TBL] [Abstract][Full Text] [Related]
11. Malignant transformation of oral leukoplakia: Systematic review and meta-analysis of the last 5 years.
Aguirre-Urizar JM; Lafuente-Ibáñez de Mendoza I; Warnakulasuriya S
Oral Dis; 2021 Nov; 27(8):1881-1895. PubMed ID: 33606345
[TBL] [Abstract][Full Text] [Related]
12. Identification of a combined biomarker for malignant transformation in oral submucous fibrosis.
Bazarsad S; Zhang X; Kim KY; Illeperuma R; Jayasinghe RD; Tilakaratne WM; Kim J
J Oral Pathol Med; 2017 Jul; 46(6):431-438. PubMed ID: 27497264
[TBL] [Abstract][Full Text] [Related]
13. What is the malignant transformation potential of oral lichen planus?
Offen E; Allison JR
Evid Based Dent; 2022 Mar; 23(1):36-37. PubMed ID: 35338329
[TBL] [Abstract][Full Text] [Related]
14. Malignant Transformation Rate of Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis.
Murthy V; Mylonas P; Carey B; Yogarajah S; Farnell D; Addison O; Cook R; Escudier M; Diniz-Freitas M; Limeres J; Monteiro L; Silva L; Fricain JC; Catros S; Fenelon M; Lodi G; Lombardi N; Brailo V; Ariyaratnam R; López-López J; Albuquerque R
J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407401
[TBL] [Abstract][Full Text] [Related]
15. Emerging role of cellular senescence in the pathogenesis of oral submucous fibrosis and its malignant transformation.
Sharma M; Hunter KD; Fonseca FP; Radhakrishnan R
Head Neck; 2021 Oct; 43(10):3153-3164. PubMed ID: 34227702
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of HIF-1alpha in malignant transformation of oral submucous fibrosis.
Tilakaratne WM; Iqbal Z; Teh MT; Ariyawardana A; Pitiyage G; Cruchley A; Stewart JE; Hagi-Pavli E; Lalli A; Waseem A; Parkinson EK; Fortune F
J Oral Pathol Med; 2008 Jul; 37(6):372-7. PubMed ID: 18221327
[TBL] [Abstract][Full Text] [Related]
17. Nuclear Blebbing Frequency in Tobacco-Induced Oral Potentially Malignant Disorders: A Pilot Study.
Yadahalli R; Kheur S; Adwani A; Bhonde R; Raj AT; Patil S
Acta Cytol; 2021; 65(5):403-410. PubMed ID: 34120116
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of curcumin for management of oral submucous fibrosis: a systematic review of randomized clinical trials.
Al-Maweri SA
Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Apr; 127(4):300-308. PubMed ID: 30745280
[TBL] [Abstract][Full Text] [Related]
19. Molecular Pathology of Malignant Transformation of Oral Submucous Fibrosis.
Chattopadhyay A; Ray JG
J Environ Pathol Toxicol Oncol; 2016; 35(3):193-205. PubMed ID: 27910776
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of oral submucous fibrosis. Relationship to risk factors associated with oral cancer.
Pillai R; Balaram P; Reddiar KS
Cancer; 1992 Apr; 69(8):2011-20. PubMed ID: 1544110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
